Feasibility and clinical utility of home-based fecal immunochemical testing for self-monitoring of disease activity in ulcerative colitis
Crohn’s & Colitis 360 · 22.04.2026 · 8 (2)
DOI: 10.1093/crocol/otag025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crohn’s & Colitis 360, online erschienen am 07.04.2026. Verfasst von Yuki Aoyama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology.
Abstract (Originalsprache)
Background
Home-based quantitative fecal calprotectin testing has been used to improve the prognosis of ulcerative colitis (UC) patients. However, its cost and the need for specific measurement devices limit accessibility. This study explored the potential of the home-based fecal immunochemical test (FIT) for self-monitoring in patients with UC.
Methods
In this prospective cohort study, we recruited patients in clinical remission who were scheduled for colonoscopy between October 2020 and October 2021. We evaluated the correlation between home-based qualitative FIT results obtained using a commercially available kit and hospital-based quantitative fecal markers, endoscopic activity, and treatment intensification. We also assessed the feasibility of continued home-based FIT.
Results
Among the 54 enrolled patients, 38 tested negative and 16 tested positive using the home-based FIT. The FIT-negative patients had significantly lower hospital-based FIT and fecal calprotectin levels than the FIT-positive patients (P < .0001 and P = .0029, respectively). The accuracy of home-based FIT for predicting endoscopic remission was 0.83, which was comparable to that of hospital-based FIT (0.85) and fecal calprotectin (0.79). None of the 38 FIT-negative patients required intensification of treatment. Among the 20 patients eligible for continued home-based FIT, the adherence rate over one year was 97.0% (82.1%-100%). Notably, none of the 8 FIT-negative patients experienced clinical relapse, whereas those with at least one FIT-positive showed a higher tendency for clinical relapse (P = .055).
Conclusions
Home-based FIT is a feasible, accurate, and well-accepted tool for monitoring remission in UC and is comparable to hospital-based fecal markers (UMIN000040572).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
- Research Center for Intestinal Health Science, Okayama University, Okayama, Japan.
ORCID-Profile: Sakiko Hiraoka
Förderung
- Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology
Zitieren
APA
Aoyama, Y., Inokuchi, T., Hiraoka, S., Ishiguro, M., Igawa, S., Takeuchi, K., Takahara, M., Toyosawa, J., Yamasaki, Y., Kinugasa, H., & Otsuka, M. (2026). Feasibility and clinical utility of home-based fecal immunochemical testing for self-monitoring of disease activity in ulcerative colitis. Crohn’s & Colitis 360, 8(2). https://doi.org/10.1093/crocol/otag025
Vancouver
Aoyama Y, Inokuchi T, Hiraoka S, Ishiguro M, Igawa S, Takeuchi K, et al. Feasibility and clinical utility of home-based fecal immunochemical testing for self-monitoring of disease activity in ulcerative colitis. Crohn’s & Colitis 360. 2026;8(2). doi:10.1093/crocol/otag025
BibTeX
@article{Aoyama2026,
author = {Aoyama, Yuki and Inokuchi, Toshihiro and Hiraoka, Sakiko and Ishiguro, Mikako and Igawa, Shoko and Takeuchi, Keiko and Takahara, Masahiro and Toyosawa, Junki and Yamasaki, Yasushi and Kinugasa, Hideaki and Otsuka, Motoyuki},
title = {Feasibility and clinical utility of home-based fecal immunochemical testing for self-monitoring of disease activity in ulcerative colitis},
journal = {Crohn’s & Colitis 360},
year = {2026},
volume = {8},
number = {2},
doi = {10.1093/crocol/otag025}
}
EUVIMED